50242-159Level 3
Lunsumio (Mosunetuzumab)
**Product type:** Human Prescription Drug
**Active ingredient:** MOSUNETUZUMAB
**Strength:** 1 mg/mL
**Dosage form:** Concentrate
**Route:** Intravenous
**Labeler:** Genentech, Inc.
**Marketing category:** BLA (BLA761263)
GET
/api/v1/systems/ndc_fda/nodes/50242-159Hierarchy Explorer
Loading...
Cross-system equivalences0
No cross-system equivalences mapped for this node.